Madhu Chopra
7PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 20, 2024
Identification of novel inhibitors of cancer target telomerase using a dual structure-based pharmacophore approach to virtually screen libraries, molecular docking and validation by molecular dynamics simulations.Divpreet Kaur, Daman Saluja, Madhu Chopra
|Sep 30, 2024
Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity.Vineeta Teotia, Prakash Jha, Madhu Chopra
|Oct 10, 2022
Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.Priya Poonia, Monika Sharma, Prakash Jha
|Sep 29, 2022
Ricolinostat suppresses proliferation, promotes apoptosis, and enhances the antiproliferative activity of topoisomerase inhibitors in cervical cancer cells.Sumeet Kaur, Prerna Rajoria, Madhu Chopra
|Aug 29, 2022
HDAC6: A unique HDAC family member as a cancer target.Sumeet Kaur, Prerna Rajoria, Madhu Chopra
|Jan 23, 2019
Combined comparative molecular field analysis, comparative molecular similarity indices analysis, molecular docking and molecular dynamics studies of histone deacetylase 6 inhibitors.Monika Sharma, Prakash Jha, Priyanka Verma
Pageof 2
